BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 23, 2007
View Archived Issues
Synergistic effects of triple antiangiogenic therapy in preclinical models of neovascularization
Read More
PRX-302 shows promise for prostate cancer
Read More
Intravenous cannabinor shows no efficacy benefit in capsaicin-induced pain
Read More
New phase II study for PEP-005 Topical in actinic keratosis
Read More
FTC clears Hospira's acquisition of Mayne Pharma
Read More
Tentative approval for Barr's generic version of Kytril
Read More
Bionovo opens pharmacokinetics study of MF-101
Read More
Nalbuphine ER begins phase I safety study for pain
Read More
Bayer Schering signs agreement for novel neurodegenerative imaging compounds
Read More
MBP-8298 cleared to begin U.S. phase III study in secondary progressive MS
Read More
Recent Janssen and Aska patents report new therapeutic agents for urological disorders
Read More
Recent Merck, Ambrilia and AnorMED patents disclose novel therapeutics for HIV infection
Read More
Safety data from the STAR study presented
Read More
No benefit of adding bevacizumab to standard therapy in pancreatic cancer
Read More
New treatment options for cardiovascular disorders imparted in recent patents
Read More
Addition of bevacizumab to chemotherapy improves progression-free survival in MCRC patients
Read More
Final results from the ACTS-GC trial announced
Read More
AnGes inlicenses Naglazyme for Japan
Read More
Iomai awarded contract for adjuvant patch for use with pandemic influenza vaccine
Read More
Novel orally active oxytocin receptor antagonist profiled at GlaxoSmithKline
Read More
Novartis and Mochida to copromote Diovan in Japan
Read More
Johns Hopkins team reports favorable data on pancreatic cancer vaccine
Read More
FDA grants orphan drug status for droxidopa in neurogenic orthostatic hypotension
Read More
